MAP Pharmaceuticals, Inc. 4
4 · MAP Pharmaceuticals, Inc. · Filed Feb 16, 2010
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock
2010-02-11−1,250,000→ 2,826,169 total
Footnotes (2)
- [F1]All of the securities reported herein (the "Shares") are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros").
- [F2]On February 11, 2010, Perseus-Soros distributed 1,250,000 shares of the Issuers Common Stock pro rata to its partners for no consideration. Certain partners of Perseus-Soros have made subsequent pro rata distribution of shares received to their respective partners or members for no consideration.